The Telangana Anti-Corruption Bureau (ACB) on Thursday conducted simultaneous searches in the offices and residences of officials of Insurance Medical Services (IMS) and others as part of its probe into alleged scam in purchase of medicines for state-run hospitals and dispensaries.
The bureau, directed by the government to take up the probe, said it has found the Director of IMS and other officials were "involved in making fake indents, falsification of records, violating the rules and regulations in purchase of medicines, surgical kits and caused loss to the exchequer.
A case has been registered under the Prevention of Corruption Act and Indian Penal Code sections and the searches were conducted at the offices and residences of Director and Joint Director of IMS and 15 other officials besides at the premises of four private individuals, including a reporter of a Telugu TV channel, the ACB said in a release here.
In all, searches were being carried out at 21 places in the city and one place each in Warrangal and Mahabubabad.
Earlier, the vigilance and enforcement wing had held an inquiry into the allegations that no proper eligibility criteria was followed by the Director of IMS in the selection of firms for supply of medicines.
The wing, which filed a report in March this year, had found medicines were bought at exorbitant prices, in violation of the procurement procedures and the e-tender processes. Listing the alleged irregularities, the ACB release said among others two fake indents for medicines worth Rs 1.03 crore were prepared by the Joint Director in May last year and the bills were passed by the Director.
Similarly, medicines worth Rs 1.23 crore were indented and received by the Joint Director but the stock was not sent to the dispensaries, it said.
Another allegation was that the Director and other officials caused a loss of Rs 9.43 crore tothegovernment in purchase of medicines through 2017-18. The case was under further investigation, the release added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
